723760-74-5

Basic information

• Product Name: 5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one
• Synonyms: 5-bromo-6-nitro-1-indanone;5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one
• CAS NO: 723760-74-5
• Molecular Formula: C9H6BrNO3
• Molecular Weight: 256
• Mol File: 723760-74-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one(723760-74-5)
• EPA Substance Registry System: 5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one(723760-74-5)

Safety Data

• Hazardous Substances Data: 723760-74-5(Hazardous Substances Data)

Usage

General Description

5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one, also known as Bromonitromethylenecyclohexane, is a chemical compound that is used as a reagent in organic synthesis. It is a yellow crystalline solid with the molecular formula C9H6BrNO3, and it is commonly used in the pharmaceutical and agrochemical industries. 5-bromo-6-nitro-2,3-dihydro-1H-inden-1-one is known for its ability to undergo substitution reactions, and it is often used as a building block in the synthesis of various organic compounds. It is important to handle this compound with caution, as it may be hazardous if not handled properly.

InChI:InChI=1S/C9H6BrNO3/c10-7-3-5-1-2-9(12)6(5)4-8(7)11(13)14/h3-4H,1-2H2

Upstream product

• 34598-49-7 5-Bromo-1-indanone 

Downstream Products

• 1260018-10-7 5-bromo-6-chloroindan-1-one 

Relevant articles and documents

Photoactivated enediynes: Targeted chimeras which undergo photo-Bergman cyclization

Enediyne chimeras containing a photoactivated warhead coupled to either a porphyrin or nucleic acid binding motif were prepared via Pd coupling methodology. Photoactivation was achieved in both cases, paving the way for application in photodynamic therapy

Pyridine compound, its preparation and use (by machine translation)

The invention relates to pyridine compounds or their pharmaceutically acceptable salts, stereoisomers, polymorphs, solvates, N - oxide, an isotope-labeled compound, metabolite or prodrug. The invention also relates to a pharmaceutical composition comprisi

INDENONCARBOXYLIC ACIDS DERIVATIVES AND THEIR USE FOR THE TREATMENT OF AND PREVENTING DIABETES AND DYSLIPIDAEMIA

The present invention relates to a compound of the formula ((I): in which: n is an integer chosen from 1, 2 and 3; Y represents O; N-OR9, in which R9represents H or a saturated hydrocarbon-based aliphatic group; CR10R